发明名称 | Application of 5-HT<sub>6 </sub>receptor antagonists for the alleviation of cognitive deficits of down syndrome | ||
摘要 | Methods for treating Down syndrome and improving cognitive function of a patient with an intellectual disability are disclosed. 5-hydroxytryptamine sub-receptor six (5-HT6) receptor antagonists are provided for improving the cognition of a Down syndrome patient. | ||
申请公布号 | US9029379(B2) | 申请公布日期 | 2015.05.12 |
申请号 | US201313837887 | 申请日期 | 2013.03.15 |
申请人 | The University of Utah Research Foundation | 发明人 | Korenberg Julie Ruth;Wilcox Karen Sue;West Peter Jeffrey;Kesner Raymond Pierre |
分类号 | A61K31/496;A61K31/506;A61K31/4045;A61K31/4985;A61K31/454;C07D487/04;A61K31/404;A61K31/4745;A61K31/505;A61K31/495;A61K45/06;C07D209/14;C07D239/50;C07D295/096;C07D401/04;C07D401/10 | 主分类号 | A61K31/496 |
代理机构 | Stoel Rives LLP | 代理人 | Stoel Rives LLP |
主权项 | 1. A method of treating Down syndrome, comprising administering to a subject in need thereof an effective amount of a 5-HT6 receptor antagonist, wherein the 5-HT6 receptor antagonist is an effective amount of a compound selected from: compound 1, compound 2, compound 3, compound 4, compound 5, compound 6, and/or compound 7, having the chemical formula: or pharmaceutically acceptable hydrates, solvates, tautomers, salts and complexes thereof. | ||
地址 | Salt Lake City UT US |